Moneycontrol
SENSEX NIFTY
YOU ARE HERE >  Moneycontrol Markets > Announcements Pharmaceuticals

Sun Pharma Advanced Research Company

BSE: 532872|NSE: SPARC|ISIN: INE232I01014|SECTOR: Pharmaceuticals
SET ALERT
|
ADD TO PORTFOLIO
|
WATCHLIST
LIVE
BSE
Nov 20, 16:00
393.30
1.45 (0.37%)
VOLUME 37,187
LIVE
NSE
Nov 20, 15:56
393.20
1.1 (0.28%)
VOLUME 85,084
Announcements on Sun Pharma Adv

27th-Oct-2017 19:08Source: BSE

Sun Pharma Advanced Research Company- Outcome of Board Meeting

The Board of Directors of the Company at their meeting held from 05:00 pm to 07:00 pm today, inter alia, took on record and duly approved the Un-audited financial results of the Company for the quarte...

19th-Oct-2017 10:22Source: BSE

Sun Pharma Advanced Research Company- Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011

The Exchange has received the disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Jayant S Sanghvi

14th-Oct-2017 18:25Source: BSE

Sun Pharma Advanced Research Company- PCS Certificate Under Regulation 40(9) For The Half Year Ended 30Th September 2017

As per the requirements of Regulation 40(10) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find herewith the Compliance Certificate dated 18th April 2016 issu...

12th-Oct-2017 09:51Source: BSE

Sun Pharma Adv- Shareholding for the Period Ended September 30, 2017

Sun Pharma Advanced Research Company Ltd has submitted to BSE the Shareholding Pattern for the Period Ended September 30, 2017. For more details, kindly

11th-Oct-2017 16:10Source: BSE

Sun Pharma Adv- Board Meeting On Friday, 27Th October 2017

Pursuant to regulation 29 (1) of the SEBI (Listing obligation & Disclosure Requirements) Regulation, 2015, we hereby inform you that a meeting of the Board of Directors of Sun Pharma Advanced Research...

10th-Oct-2017 12:18Source: BSE

Sun Pharma Adv- Statement Of Investor Compliance For The Quarter Ended 30Th September 2017

Pursuant to regulation 13(3) of the SEBI (Listing Obligation and Disclosure Requirements) Regulations, 2015, please find below statement of Investor Complaints of the Company for the quarter ended 30t...

6th-Oct-2017 16:57Source: BSE

Sun Pharma Adv- Press Release / Media Release

Pursuant to regulation 30 of the SEBI (Listing Obligation & Disclosure Requirements) Regulations, 2015, we enclose herewith the Press Release on SPARC Provides Update on Two Pivotal Phase III Studies ...

5th-Oct-2017 18:03Source: BSE

Sun Pharma Adv- Compliance Certificate Under Reg 7(3) Of SEBI LODR For The Half Year Ended 30Th September 2017

Pursuant to the requirement of Regulation 7 (3) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby confirm that activities in relation to both physical and elec...

28th-Sep-2017 11:42Source: BSE

Sun Pharma Adv- Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011

The Exchange has received the disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Sudhir Valia

15th-Sep-2017 16:04Source: BSE

Sun Pharma Adv- Updates

Update on Company Information

1 2 3 4 5 Next >>
Quick Links for Sun Pharma Advanced Research Company
Explore Moneycontrol
Stocks     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z | Others
Mutual Funds     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z
Copyright © e-Eighteen.com Ltd. All rights reserved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express written permission of moneycontrol.com is prohibited.